Veterinary Medicines

Cylanic 500 mg + 125 mg tablets for dogs

Authorised
  • Amoxicillin trihydrate
  • Potassium clavulanate
Download as PDF

Product identification

Medicine name:
Cylanic 500 mg + 125 mg tablets for dogs
CYLANIC 500 mg + 125 mg, tabletės šunims
Active substance:
  • Amoxicillin trihydrate
  • Potassium clavulanate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    574.03
    milligram(s)
    /
    1.00
    Tablet
  • Potassium clavulanate
    148.91
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Available in:
  • Lithuania
Package description:
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 250 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 100 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 50 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 30 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each.Package sizes:Cardboard box of 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Livisto Int'l S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
  • Lelypharma B.V.
  • aniMedica Herstellungs GmbH
  • Industrial Veterinaria S.A.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/21/2667/001-005
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0582/003
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download

RV2667.pdf

Lithuanian (PDF)
Published on: 26/07/2022
Download
How useful was this page?:
Average: 1 (3 votes)
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."